All Type of News
HIRAS removes 15 medicines from health insurance list
The Health Insurance Review and assessment Service (HIRAS) removed a total of 1,111 drugs confirmed to have used talc contaminated with asbestos, from eligible health insurance list on April 13.
Last week, 1,122 me...
Zydena debuts in Russia
Dong-A Pharmaceutical says its erectile dysfunction drug Zydena (udenafil) has been recently launched by Valenta in Russia.
Dong-A signed an agreement with Valenta (formerly OTECHESTVENNYE JSC), one of Russia’s lar...
Ilsung in race for anti-obesity drug market
Ilsung Pharm announced an ambitious target for its recently launched Reductra 15 capsule, sibutramine generic product
Ilsung said the company aims to take up a bigger market share of Reductra in the first year of m...
Choong-wae, Kaken enter into exclusive agreement for marketing of butenafine hydrochloride cream
Choong-wae Shinyak, an affiliated company of Choongp-wae Holdings and Kaken Pharmaceutical Co. announced on April 13 that they have concluded a basic agreement on the exclusive marketing in Korea by Choong-wae of topi...
Asbestos-free medicines will be released in 15 days
Pharmaceutical firms are busy replacing talc-tainted medicines with asbestos as the government banned the sales of 1,111 medicinal products on April 9.
“It will take about 15 days to replace older medicines with ne...
Health insurance to exclude asbestos-tainted 1,071 drugs
The ministry of Health, Welfare and Family Affairs said a total of 1,071 medicines have not been in a list of insurance medicines as of April 9, as these drugs were found to have used talc contaminated with asbestos.
...
Discontent mounting over drug sales ban
There is growing dissatisfaction in the local pharmaceutical industry as the country's food agency issued sales bans and recall orders on April 9 over 1,122 drugs and medical goods confirmed to have used talc contamin...
Drugmakers face weaker won
It is a challenging time for leading domestic pharmaceutical firms – Dong-A Pharm, Yuhan Corporation and Daewoong Pharm - to cope with the won's weakness against major currencies.
“The hike of raw material prices a...
Bio stocks emerge as leading theme
Bio-related stocks, including Diostech and Celltrion, have rallied as more foreigners are replacing institutional investors to lead the bullish trend of the tech-heavy Kosdaq.
According to FnGuide, an online financ...
1,122 drugs to be banned, KFDA says
The Korea Food and Drug Administration banned the sales of 1,122 medicines produced by 120 medical companies and medical goods confirmed to have used talc contaminated with asbestos, it was announced on April 9. It sa...
